tradingkey.logo

Pulmonx Corp <LUNG.OQ> expected to post a loss of 40 cents a share - Earnings Preview

ReutersApr 28, 2025 9:04 PM
  • Pulmonx Corp LUNG.OQ LUNG.O is expected to show a rise in quarterly revenue when it reports results on April 30 for the period ending March 31 2025

  • The Redwood City California-based company is expected to report a 16.9% increase in revenue to $22.034 million from $18.85 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Pulmonx Corp is for a loss of 40 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Pulmonx Corp is $12.00​, above​ its last closing price of $5.20. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.44

-0.45

-0.33

Beat

26.3

Sep. 30 2024

-0.45

-0.45

-0.36

Beat

19.7

Jun. 30 2024

-0.42

-0.43

-0.35

Beat

17.7​

Mar. 31 2024

-0.45

-0.46

-0.36

Beat

22

​​Dec. 31 2023

-0.38

-0.41

-0.36

Beat

11.6

Sep. 30 2023

-0.42

-0.43

-0.39

Beat

8.8​

Jun. 30 2023

-0.44

-0.44

-0.43

Beat

1.6

Mar. 31 2023

-0.44

-0.44

-0.42

Beat

4.5

This summary was machine generated April 28 at 21:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI